Allergic rhinitis affects an estimated 15% of the US population and is associated with impaired quality of life. JAMA Deputy Editor Mary McGrae McDermott, MD, discusses current evidence regarding the diagnosis and treatment of allergic rhinitis with author Jonathan A. Bernstein, MD, College of Medicine, University of Cincinnati.
Related Content:
Who Was Nathan Pritikin and Why Is There a Diet Named After Him?
COVID-19 in Seattle: Clinical Features and Managing the Outbreak
The Effect of the COVID-19 Pandemic on Clinic Operations
Update on Coronavirus: March 6, 2020, by NIAID’s Anthony Fauci, MD
Unprofessional Behavior Leads to Complications
AIDS-Related Chronic Inflammation Leading to Chronic Disease
The 2020 Influenza Epidemic—More Serious Than Coronavirus in the US
Parkinson Disease
Testing for Breast Cancer Susceptibility Genes
Management of Chronic Stable Angina in 2020
Treating Conjunctivitis and Dry Eye Disease
2019 Novel Coronavirus: An Update From NIAID Director Anthony Fauci, MD
Football Players and Erectile Dysfunction Associated With Repetitive Head Injury
The Keto, Atkins, and Pritikin Diets
The Keto Diet: Advice for Patients
The American Heart Association Takes a Stance Against e-Cigarettes
An Inconvenient Tooth
NICE Guidelines for Heavy Menstrual Bleeding: What to Make of Them
The Medical and Political Response to the 2019 Christchurch Mosque Mass Shooting
What Do I Need to Know About e-Cigarettes and If They Help People Stop Smoking?
Create your
podcast in
minutes
It is Free
Good Mood Revolution
JAMA Editors’ Summary
JAMA Medical News
JAMAevidence The Rational Clinical Examination
JAMA Psychiatry Author Interviews
JAMA Internal Medicine Author Interviews